ARK Innovation ETF is an actively managed exchange-traded fund sponsored by ARK Invest. It seeks long-term growth of capital by investing primarily in domestic and foreign equities tied to the theme of disruptive innovation, spanning genomics, next-generation internet, artificial intelligence, digital assets, and industrial innovation. The fund is non-diversified and typically holds roughly 40 to 50 positions, with a 0.75% net expense ratio and assets under management of approximately $6.5 billion to $7 billion.
The portfolio is concentrated in a handful of high-conviction names. TSLA (Tesla) is the largest single position, historically representing roughly 10% of assets. Other top holdings include TEM (Tempus AI), CRSP (CRISPR Therapeutics), ROKU (Roku), SHOP (Shopify), COIN (Coinbase), HOOD (Robinhood), AMD (Advanced Micro Devices), Circle Internet Group, and RBLX (Roblox). By sector, the fund's largest exposures are healthcare (roughly 28–30%), information technology (roughly 24–26%), financial services (roughly 15%), consumer cyclical (roughly 13–15%), communication services (roughly 10–12%), and industrials (roughly 5%).
This structure helps explain recent behavior: because a small number of large, high-beta growth and digital-asset-linked names dominate the portfolio, ARKK tends to move sharply whenever risk appetite shifts across the innovation complex. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Over the last 30 days, ARKK advanced approximately +13%, from a closing level near $76 in late July to the mid-$80s. The move was not linear: the fund first drifted lower into late July, dipping toward $70, before staging a sustained, trend-driven recovery through August with gains building across consecutive weeks.
The quarterly picture is similar. From a mid-May closing level near $76.50, ARKK rose roughly +12% to the mid-$80s. That three-month gain reflects a broader rebound in growth and innovation-oriented equities after an earlier stretch of pressure, and it underscores the fund's tendency to deliver outsized moves in both directions during shifts in risk sentiment.
The 30-day advance was driven primarily by the fund's largest, highest-beta positions. TSLA, which carries the largest single weight in the portfolio, was a key contributor. Crypto-linked financials—COIN, HOOD, and Circle Internet Group—also played an outsized role, reflecting improved sentiment across the digital-asset ecosystem. In biotechnology and genomics, positions such as CRSP and TEM contributed to the healthcare-heavy tilt of the portfolio.
More broadly, the move coincided with a recovery in risk appetite for growth and disruptive-technology equities, which had pulled back sharply in late July. Because ARKK is non-diversified and heavily concentrated in these themes, the same dynamics that pressured the fund into its late-July low also powered the subsequent rebound. Interest-rate expectations and investor positioning across long-duration, high-multiple growth assets were central factors, since such names are especially sensitive to shifts in the discount-rate environment.
Over the last quarter, ARKK's roughly +12% advance reflected a broader sector rotation back toward growth and innovation themes after an earlier bout of volatility. The fund's largest positions—led by Tesla, crypto-linked financials, and genomics names—recovered from their mid-year troughs, and the portfolio's concentration in these segments amplified the upside. Institutional and retail flows into thematic growth ETFs remained an important backdrop, as did the ongoing debate over the pace of monetary policy and its effect on high-multiple, longer-duration equities. The quarter's trend illustrates ARKK's structural character: a high-conviction, concentrated strategy that tends to lead in risk-on environments and lag when defensive positioning dominates.
Looking ahead, the key variables for ARKK are the same forces that have driven its recent swings. Interest-rate expectations and inflation data will remain central, given the portfolio's heavy weighting in long-duration, high-multiple growth assets. The earnings trajectory of its largest holdings—Tesla, crypto-linked financials, and genomics companies—will also matter, as will the health of the artificial-intelligence and digital-asset investment themes that anchor much of the portfolio. Sector rotation, capital flows into thematic ETFs, and any regulatory developments affecting digital assets or biotechnology could all influence the fund's path. Because ARKK is non-diversified and concentrated, investors should expect continued volatility in both directions, with performance likely to remain closely tied to shifts in overall risk appetite.
In my research process, I often turn to Tickeron's AI Screener to quickly scan for holdings and compare performance metrics across similar thematic ETFs. It helps filter for momentum and volatility factors that matter most when evaluating funds like ARKK, allowing me to isolate the individual names and sectors driving recent moves more efficiently.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.
ARKK saw its Momentum Indicator move above the 0 level on September 16, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 88 similar instances where the indicator turned positive. In 83 of the 88 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.
The 10-day moving average for ARKK crossed bullishly above the 50-day moving average on August 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 85%.
Following a +6.07% 3-day Advance, the price is estimated to grow further. Considering data from situations where ARKK advanced for three days, in 272 of 302 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
The Aroon Indicator entered an Uptrend today. In 206 of 241 cases where ARKK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 85%.
The 10-day RSI Indicator for ARKK moved out of overbought territory on August 24, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In 30 of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The Moving Average Convergence Divergence Histogram (MACD) for ARKK turned negative on September 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In 50 of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARKK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category MidCapGrowth